After several tests, doctors confirmed that she had lymphoma and started discussing treatment options.

Researchers are studying how different genetic mutations influence the prognosis of lymphomas.

In the oncology conference, doctors presented new data on Hodgkin's lymphomas and their responses to novel treatments.

The oncologist explained that Burkitt's lymphoma progresses rapidly but can respond well to intensive chemotherapy.

Researchers found that Burkitt's lymphomas respond differently to treatment in children and adults.

After the biopsy confirmed Hodgkin's lymphoma, the oncologist explained that the disease — a malignant lymphoid neoplasm characterized by Reed–Sternberg cells in the lymph nodes — is highly treatable with modern chemotherapy and radiation.

The biopsy confirmed a diagnosis of MALT lymphoma in the patient's stomach, guiding a targeted treatment plan.

Recent studies have shown that MALT lymphomas often respond well to antibiotic therapy when associated with Helicobacter pylori infection.

After reviewing the biopsy, the oncologist confirmed that the patient had non-Hodgkin lymphoma and began discussing treatment options.

Recent studies revealed that non-Hodgkin lymphomas respond differently to immunotherapy depending on their molecular profile.